Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

Hovione and Laxxon Medical sign partnership over 3D printed pharmaceutical applications

March 30, 2023 Medical Communications

Hovione, a CDMO, and Laxxon Medical, a pharma-technology company, have signed a strategic partnership deal to bring 3D printing technologies …
News

Genialis raises $13m in Series A funding for the development of AI/ML patient classifiers

March 29, 2023 Medical Communications

Genialis, a computational precision medicine company, has announced that it’s raised more than $13m in Series A funding, co-led by …
News

University of Dundee aids AI research for hypertension

March 29, 2023 Medical Communications

The University of Dundee has announced its involvement in a Europe-wide project which will study whether AI can improve the …
News

OctoVent and Orient EuroPharma sign licensing agreement over immunotherapeutic candidate

March 28, 2023 Medical Communications

OctoVent, subsidiary of Hepalink Pharmaceutical Group, has entered into a license agreement with Taiwan-based Orient EuroPharma (OEP). The two companies …
News

Abberior installs new STED microscope at MBC BioLabs

March 27, 2023 Medical Communications

Abberior has announced that it has placed a super-resolution STED microscope at MBC BioLabs, which is the leading San Francisco …
News

FDA releases draft of accelerated approval guidance for oncology therapeutics

March 27, 2023 Medical Communications

The FDA has released a draft of new guidance for accelerated approval for oncology therapeutics, highlighting the need for stricter …
News

University of Leipzig and SiSaf partner over Bio-Courier targeted miRNA

March 27, 2023 Medical Communications

SiSaf, an RNA delivery and therapeutics company, has announced a collaboration with the University of Leipzig to develop Bio-Courier targeted …
News

NICE recommends PTC Therapeutics’ gene therapy for NHS use

March 24, 2023 Medical Communications

NICE has recommended PTC Therapeutics’ gene therapy to the NHS for the treatment of ultra-rare disease aromatic L-amino acid decarboxylase …
News

Creative Medical Technology files FDA ODD application for Brittle Type 1 diabetes

March 24, 2023 Medical Communications

US-based biotech company Creative Medical Technology has announced that it has filed for the FDA’s Orphan Drug Designation (ODD) for …
News

European Commission delays release of major changes to pharma legislation

March 24, 2023 Medical Communications

The European Commission (EC) has again delayed the release of its new proposal for changes to Europe’s pharma legislation. The …
News

NeuroRPM announces FDA clearance for AI monitoring app for Parkinson’s disease on Apple Watch

March 24, 2023 Medical Communications

NeuroRPM has announced that it has received clearance from the FDA for its NeuroRPM device which uses AI and existing …
News

Incyte has announced FDA approval of Zynyz

March 23, 2023 Medical Communications

Incyte has today announced that the FDA gas approved Zynyz (retifanlimab-dlwr) for the treatment of adult patients with metastatic or …
News

India cancels manufacturing licence for Marion Biotech after cough syrup deaths

March 23, 2023 Medical Communications

Uttar Pradesh, a state in India, has cancelled the manufacturing licence of Marion Biotech after two cough syrups made at …
News

Roche and Eli Lilly collaborate on Alzheimer’s disease blood test

March 22, 2023 Medical Communications

Swiss biotech company Roche has announced a collaboration with US pharmaceutical company Eli Lilly to develop Roche’s Elecsys Amyloid Plasma …
News

FDA staff appear to support Biogen’s ALS drug despite limited data

March 21, 2023 Medical Communications

It appears that the FDA is inclined to support Biogen’s amyotrophic lateral sclerosis (ALS) drug, tofersen, with documents released on …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026